Stock Movers Defense Stocks and Tariffs; Monster Jumps; Gilead Higher on Earnings
Aug 8, 2025
Dive into the world of defense stocks as geopolitical tensions stir market reactions. Lockheed Martin faces challenges with tariffs impacting international deals. Meanwhile, Monster Beverage skyrockets in sales, showcasing the booming popularity of energy drinks. Gilead Sciences impresses investors by boosting its annual outlook on the back of strong HIV drug sales, driven by its flagship medication, Biktarvy. Stay tuned for insights on how these movements shape the investment landscape!
AI Snips
Chapters
Transcript
Episode notes
Geopolitics Threatens Defense Stock Momentum
- India is reconsidering planned U.S. weapons purchases, which could curb international defense contract growth.
- Kriti Gupta warns this geopolitics could pressure stocks like Lockheed, General Dynamics, and RTX.
Watch Lockheed And Peers At The Open
- Monitor Lockheed Martin, General Dynamics, and RTX at the open for spillover from trade headlines.
- Kriti Gupta says light volume makes these names vulnerable to sharp moves on new reports.
Monster's Earnings Spark Upgrades And Rally
- Monster Beverage beat revenue and earnings as global consumption rose, sending the stock up sharply.
- Wall Street firms like Piper Sandler and Citi raised price targets and ratings on the move.